Focus Partners Advisor Solutions’s Harmony Biosciences HRMY Stock Holding History

Focus Partners Advisor Solutions’s Portfolio HRMY Stock Details HRMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$228K	Buy	+5,797	New	+$224K	﹤0.01%	1228

Other funds holding HRMY

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Focus Partners Advisor Solutions's HRMY Position: Q3 2026 in Review

Focus Partners Advisor Solutions opened a new position in Harmony Biosciences (HRMY) in Q3 2026: 5,797 shares worth $228K. The stake represents ﹤0.01% of the portfolio and ranks #1228 among its holdings.

226 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.

Focus Partners Advisor Solutions held 5,797 shares of Harmony Biosciences worth $228K as of Q3 2026.
Harmony Biosciences was a new Focus Partners Advisor Solutions position in Q3 2026.
Harmony Biosciences made up ﹤0.01% of Focus Partners Advisor Solutions's portfolio in Q3 2026, its #1228 holding.
226 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q3 2026, filed 10 Nov 2026.